Literature DB >> 7779806

Solution structure of the cytoplasmic domain of phopholamban: phosphorylation leads to a local perturbation in secondary structure.

R J Mortishire-Smith1, S M Pitzenberger, C J Burke, C R Middaugh, V M Garsky, R G Johnson.   

Abstract

Peptides representing the N-terminal domain (Ia) of the cardiac sarcoplasmic reticulum protein phospholamban (residues 1-25 [PLB(1-25)] and a phosphorylated form [pPLB(1-25)]) were synthesized and their conformations examined using circular dichroism and nuclear magnetic resonance spectroscopy. In aqueous solution, both PLB(1-25) and pPLB(1-25) adopt a primarily disordered conformation. In 30% trifluoroethanol/10 mM phosphate, PLB(1-25) exhibits a CD spectrum consistent with 60% helical structure. This value decreases to 27% for the phosphorylated peptide. CD spectra in 2% SDS indicate 40% alpha-helix for PLB(1-25) and 20% for pPLB(1-25). Full chemical shift assignments were obtained by conventional homonuclear NMR methodologies for both PLB(1-25) and pPLB(1-25) in 30% trifluoroethanol/water and 300 mM SDS. The solution structure of PLB(1-25) in 30% TFE/water was determined from distance geometry calculations using 54 NOE distance constraints and 17 torsion angle constraints. In the family of 20 calculated conformers, the root mean square deviation from the mean structure is 0.79 A for backbone heavy atoms of residues 1-17. The structure comprises a regular alpha-helix extending from M1 to S16 with the remaining C-terminal residues disordered. The calculated structure is supported by analysis of C alpha H secondary shifts which are significantly negative for residues 1-16. Chemical shift degeneracy is substantially more extensive in the phospho form and precludes a direct comparison of calculated structures. However, the magnitudes of upfield secondary shifts are decreased by 20% in residues 1-11 and are not significantly helical for residues 12-16 according to the criteria of Wishart et al. [(1992) Biochemistry 31, 1647-1651]. 3JHN alpha coupling constants measured for I12, R13, A15, and S16 also suggest that residues 12-16 undergo a local unwinding of the helix upon phosphorylation. Similar results are obtained for PLB(1-25) and pPLB(1-25) in 300 mM perdeuterated sodium dodecyl sulfate except that differences in backbone dynamics for the helical and nonhelical regions of the peptide are evident in the DQF-COSY line shapes for fingerprint cross-peaks. This disruption of structure at the C-terminus of the helix suggests a model for phosphorylation-induced dissociation of the PLB/Ca(2+)-ATPase complex.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7779806     DOI: 10.1021/bi00023a006

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  19 in total

1.  Phospholamban domain IB forms an interaction site with the loop between transmembrane helices M6 and M7 of sarco(endo)plasmic reticulum Ca2+ ATPases.

Authors:  M Asahi; N M Green; K Kurzydlowski; M Tada; D H MacLennan
Journal:  Proc Natl Acad Sci U S A       Date:  2001-08-28       Impact factor: 11.205

2.  Locating phospholamban in co-crystals with Ca(2+)-ATPase by cryoelectron microscopy.

Authors:  H S Young; L R Jones; D L Stokes
Journal:  Biophys J       Date:  2001-08       Impact factor: 4.033

3.  Structure of the 1-36 N-terminal fragment of human phospholamban phosphorylated at Ser-16 and Thr-17.

Authors:  Piero Pollesello; Arto Annila
Journal:  Biophys J       Date:  2002-07       Impact factor: 4.033

4.  Computational design of a water-soluble analog of phospholamban.

Authors:  Avram M Slovic; Christopher M Summa; James D Lear; William F DeGrado
Journal:  Protein Sci       Date:  2003-02       Impact factor: 6.725

5.  Effects of phosphorylation on the intrinsic propensity of backbone conformations of serine/threonine.

Authors:  Erbin He; Guanghui Yan; Jian Zhang; Jun Wang; Wenfei Li
Journal:  J Biol Phys       Date:  2016-01-12       Impact factor: 1.365

6.  The alpha-helical propensity of the cytoplasmic domain of phospholamban: a molecular dynamics simulation of the effect of phosphorylation and mutation.

Authors:  M Germana Paterlini; David D Thomas
Journal:  Biophys J       Date:  2005-03-11       Impact factor: 4.033

7.  Interactions between Ca2+-ATPase and the pentameric form of phospholamban in two-dimensional co-crystals.

Authors:  David L Stokes; Andrew J Pomfret; William J Rice; John Paul Glaves; Howard S Young
Journal:  Biophys J       Date:  2006-03-13       Impact factor: 4.033

8.  Phospholamban remains associated with the Ca2+- and Mg2+-dependent ATPase following phosphorylation by cAMP-dependent protein kinase.

Authors:  S Negash; Q Yao; H Sun; J Li; D J Bigelow; T C Squier
Journal:  Biochem J       Date:  2000-10-01       Impact factor: 3.857

9.  An investigation of the mechanism of inhibition of the Ca(2+)-ATPase by phospholamban.

Authors:  G Hughes; A P Starling; R P Sharma; J M East; A G Lee
Journal:  Biochem J       Date:  1996-09-15       Impact factor: 3.857

10.  Structural constraints on the transmembrane and juxtamembrane regions of the phospholamban pentamer in membrane bilayers: Gln29 and Leu52.

Authors:  Wei Liu; Jeffrey Z Fei; Toru Kawakami; Steven O Smith
Journal:  Biochim Biophys Acta       Date:  2007-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.